Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis [Phase 1]

View source ↗

Summary

The update outlines a Phase 1 study to assess the safety of intravenous infusion of cultured allogeneic umbilical cord–derived mesenchymal stem cells in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Cultured allogeneic adult umbilical cord-derived mesenchymal stem cells

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Systemic Sclerosis | Phase 1 | Status: RECRUITING